The Federal Ministry of Health (BMG) has appointed new members to the Standing Committee on Vaccination (STIKO). Among the 19 experts is Dr Berit Lange, acting head of the department “Epidemiology” at the Helmholtz...
The respiratory syncytial virus (RSV) causes severe lower respiratory tract infections, particularly in young children. To date, there is neither an antiviral therapy against the virus nor a vaccination for children....
Researchers from the Würzburg Helmholtz Institute for RNA-based Infection Research (HIRI) deployed CRISPR interference for the first time for the functional characterization of the gut mutualist Bacteroides...
As Alliance of Science Organisations in Germany, we emphatically condemn all and any anti-democratic and inhumane endeavours. We vehemently reject the racist statements that have circulated in recent weeks. They are in...
On Friday, February 2, 2024, the German Research Foundation (DFG) and the German Council of Science and Humanities (WR) announced which proposals for new Clusters of Excellence will be invited to submit full proposals....
The interplay between ribonucleic acid (RNA) and proteins is not only important for maintaining cellular homeostasis but is also at the center of the tug-of-war between virus and host. Until now, there has been no...
An important question in modern life science and medical research is how the microorganisms living in and on a body influence the life processes and thus health and disease of the host organism. Scientists at Kiel...
On 23 January 2024, State Secretary Judith Pirscher from the Federal Ministry of Education and Research (BMBF) visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig. She gained an insight into the...
BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (“MDR”)...
